Low HER2 Breast Cancer: Definition & Future Plans for Management

Time: 9:00 am
day: Day Two

Details:

• Navigating clinical development for the treatment of patients with HER2-expressing solid tumors, including HER2-low tumors
• Delving into latest results and future directions

Speakers: